SCHEMBL7430351

SCHEMBL7430351

CC1(C)CC(C(C)(N)c2noc(=S)[nH]2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7428738 0.82 CTH (0.33)
SCHEMBL84552 0.68
SCHEMBL6897080 0.68 PTGS1 (0.31)
Hydrochloric Acid SCHEMBL6883551 0.61 CTH (0.33)
Hydrochloric Acid SCHEMBL6885234 0.61 CTH (0.33)
SCHEMBL24508042 0.54 APLNR (0.33)
SCHEMBL20371752 0.53
SCHEMBL1395729 0.52 ALDH1A1 (0.44)
SCHEMBL6056331 0.50 FDPS (0.41)
SCHEMBL19604224 0.49

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002508362-A 2002-03-19 JP claimed
EP-1047678-A1 1-SUBSTITUTED-1-AMINOMETHYL-CYCLOALKANE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS Warner-Lambert Company LLC (US) 2000-11-02 EP claimed
WO-1999031075-A1 1-SUBSTITUTED-1-AMINOMETHYL-CYCLOALKANE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS WARNER-LAMBERT COMPANY (US) 1999-06-24 WO claimed